 | • レポートコード：MRC309Z7851 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のフェブキソスタット錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のフェブキソスタット錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - フェブキソスタット錠の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため フェブキソスタット錠市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・40mg、80mg 用途別セグメント ・病院、診療所、その他 主要な市場プレーヤー ・Teijin Pharma Limited、Jiangsu Hengrui Pharmaceuticals Co., Ltd.、Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.、Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.、Hangzhou Zhuyangxin Pharmaceutical Co., Ltd.、Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd.、Shanghai Shengdi Pharmaceutical Co., Ltd.、Shandong Loncom Pharmaceutical Co., Ltd、Nanjing Healthnice Pharmaceutical Co., Ltd.、Takeda Pharmaceuticals、DM Pharma、Gnova Biotech、Texas Pharmaceuticals、Kabir Lifesciences、Soigner Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、フェブキソスタット錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なフェブキソスタット錠メーカーの企業概要、2019年～2022年までのフェブキソスタット錠の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なフェブキソスタット錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別フェブキソスタット錠の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのフェブキソスタット錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのフェブキソスタット錠市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびフェブキソスタット錠の産業チェーンを掲載しています。 ・第14、15章では、フェブキソスタット錠の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - フェブキソスタット錠の概要 - 種類別分析（2018年vs2022年vs2029年）：40mg、80mg - 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他 - 世界のフェブキソスタット錠市場規模・予測 - 世界のフェブキソスタット錠生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Teijin Pharma Limited、Jiangsu Hengrui Pharmaceuticals Co., Ltd.、Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.、Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.、Hangzhou Zhuyangxin Pharmaceutical Co., Ltd.、Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd.、Shanghai Shengdi Pharmaceutical Co., Ltd.、Shandong Loncom Pharmaceutical Co., Ltd、Nanjing Healthnice Pharmaceutical Co., Ltd.、Takeda Pharmaceuticals、DM Pharma、Gnova Biotech、Texas Pharmaceuticals、Kabir Lifesciences、Soigner Pharma ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：40mg、80mg ・用途別分析2018年-2029年：病院、診療所、その他 ・フェブキソスタット錠の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・フェブキソスタット錠のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・フェブキソスタット錠のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・フェブキソスタット錠の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・フェブキソスタット錠の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Febuxostat Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Febuxostat Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Febuxostat Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Pieces), and average selling prices (US$/Piece), 2018-2029
Global Febuxostat Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pieces), and average selling prices (US$/Piece), 2018-2029
Global Febuxostat Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pieces), and average selling prices (US$/Piece), 2018-2029
Global Febuxostat Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Pieces), and ASP (US$/Piece), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Febuxostat Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Febuxostat Tablets market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teijin Pharma Limited, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd., Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. and Hangzhou Zhuyangxin Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Febuxostat Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
40mg
80mg
Market segment by Application
Hospital
Clinic
Other
Major players covered
Teijin Pharma Limited
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.
Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.
Hangzhou Zhuyangxin Pharmaceutical Co., Ltd.
Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd.
Shanghai Shengdi Pharmaceutical Co., Ltd.
Shandong Loncom Pharmaceutical Co., Ltd
Nanjing Healthnice Pharmaceutical Co., Ltd.
Takeda Pharmaceuticals
DM Pharma
Gnova Biotech
Texas Pharmaceuticals
Kabir Lifesciences
Soigner Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Febuxostat Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Febuxostat Tablets, with price, sales, revenue and global market share of Febuxostat Tablets from 2018 to 2023.
Chapter 3, the Febuxostat Tablets competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Febuxostat Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Febuxostat Tablets market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Febuxostat Tablets.
Chapter 14 and 15, to describe Febuxostat Tablets sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Febuxostat Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Febuxostat Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 40mg
1.3.3 80mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Febuxostat Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Febuxostat Tablets Market Size & Forecast
1.5.1 Global Febuxostat Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Febuxostat Tablets Sales Quantity (2018-2029)
1.5.3 Global Febuxostat Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teijin Pharma Limited
2.1.1 Teijin Pharma Limited Details
2.1.2 Teijin Pharma Limited Major Business
2.1.3 Teijin Pharma Limited Febuxostat Tablets Product and Services
2.1.4 Teijin Pharma Limited Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teijin Pharma Limited Recent Developments/Updates
2.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
2.2.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
2.2.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
2.2.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Febuxostat Tablets Product and Services
2.2.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
2.3 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd.
2.3.1 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Details
2.3.2 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Major Business
2.3.3 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Febuxostat Tablets Product and Services
2.3.4 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd. Recent Developments/Updates
2.4 Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd.
2.4.1 Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Details
2.4.2 Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Major Business
2.4.3 Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Febuxostat Tablets Product and Services
2.4.4 Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Xuzhou Wanbang Jinqiao Pharmaceutical Co., Ltd. Recent Developments/Updates
2.5 Hangzhou Zhuyangxin Pharmaceutical Co., Ltd.
2.5.1 Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Details
2.5.2 Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Major Business
2.5.3 Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Febuxostat Tablets Product and Services
2.5.4 Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hangzhou Zhuyangxin Pharmaceutical Co., Ltd. Recent Developments/Updates
2.6 Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd.
2.6.1 Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. Details
2.6.2 Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. Major Business
2.6.3 Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. Febuxostat Tablets Product and Services
2.6.4 Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jiangsu Wanbang Biochemical Pharmaceutical Group Co., Ltd. Recent Developments/Updates
2.7 Shanghai Shengdi Pharmaceutical Co., Ltd.
2.7.1 Shanghai Shengdi Pharmaceutical Co., Ltd. Details
2.7.2 Shanghai Shengdi Pharmaceutical Co., Ltd. Major Business
2.7.3 Shanghai Shengdi Pharmaceutical Co., Ltd. Febuxostat Tablets Product and Services
2.7.4 Shanghai Shengdi Pharmaceutical Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai Shengdi Pharmaceutical Co., Ltd. Recent Developments/Updates
2.8 Shandong Loncom Pharmaceutical Co., Ltd
2.8.1 Shandong Loncom Pharmaceutical Co., Ltd Details
2.8.2 Shandong Loncom Pharmaceutical Co., Ltd Major Business
2.8.3 Shandong Loncom Pharmaceutical Co., Ltd Febuxostat Tablets Product and Services
2.8.4 Shandong Loncom Pharmaceutical Co., Ltd Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Nanjing Healthnice Pharmaceutical Co., Ltd.
2.9.1 Nanjing Healthnice Pharmaceutical Co., Ltd. Details
2.9.2 Nanjing Healthnice Pharmaceutical Co., Ltd. Major Business
2.9.3 Nanjing Healthnice Pharmaceutical Co., Ltd. Febuxostat Tablets Product and Services
2.9.4 Nanjing Healthnice Pharmaceutical Co., Ltd. Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Nanjing Healthnice Pharmaceutical Co., Ltd. Recent Developments/Updates
2.10 Takeda Pharmaceuticals
2.10.1 Takeda Pharmaceuticals Details
2.10.2 Takeda Pharmaceuticals Major Business
2.10.3 Takeda Pharmaceuticals Febuxostat Tablets Product and Services
2.10.4 Takeda Pharmaceuticals Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Takeda Pharmaceuticals Recent Developments/Updates
2.11 DM Pharma
2.11.1 DM Pharma Details
2.11.2 DM Pharma Major Business
2.11.3 DM Pharma Febuxostat Tablets Product and Services
2.11.4 DM Pharma Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 DM Pharma Recent Developments/Updates
2.12 Gnova Biotech
2.12.1 Gnova Biotech Details
2.12.2 Gnova Biotech Major Business
2.12.3 Gnova Biotech Febuxostat Tablets Product and Services
2.12.4 Gnova Biotech Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Gnova Biotech Recent Developments/Updates
2.13 Texas Pharmaceuticals
2.13.1 Texas Pharmaceuticals Details
2.13.2 Texas Pharmaceuticals Major Business
2.13.3 Texas Pharmaceuticals Febuxostat Tablets Product and Services
2.13.4 Texas Pharmaceuticals Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Texas Pharmaceuticals Recent Developments/Updates
2.14 Kabir Lifesciences
2.14.1 Kabir Lifesciences Details
2.14.2 Kabir Lifesciences Major Business
2.14.3 Kabir Lifesciences Febuxostat Tablets Product and Services
2.14.4 Kabir Lifesciences Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Kabir Lifesciences Recent Developments/Updates
2.15 Soigner Pharma
2.15.1 Soigner Pharma Details
2.15.2 Soigner Pharma Major Business
2.15.3 Soigner Pharma Febuxostat Tablets Product and Services
2.15.4 Soigner Pharma Febuxostat Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Soigner Pharma Recent Developments/Updates
3 Competitive Environment: Febuxostat Tablets by Manufacturer
3.1 Global Febuxostat Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Febuxostat Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Febuxostat Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Febuxostat Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Febuxostat Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Febuxostat Tablets Manufacturer Market Share in 2022
3.5 Febuxostat Tablets Market: Overall Company Footprint Analysis
3.5.1 Febuxostat Tablets Market: Region Footprint
3.5.2 Febuxostat Tablets Market: Company Product Type Footprint
3.5.3 Febuxostat Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Febuxostat Tablets Market Size by Region
4.1.1 Global Febuxostat Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Febuxostat Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Febuxostat Tablets Average Price by Region (2018-2029)
4.2 North America Febuxostat Tablets Consumption Value (2018-2029)
4.3 Europe Febuxostat Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Febuxostat Tablets Consumption Value (2018-2029)
4.5 South America Febuxostat Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Febuxostat Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Febuxostat Tablets Sales Quantity by Type (2018-2029)
5.2 Global Febuxostat Tablets Consumption Value by Type (2018-2029)
5.3 Global Febuxostat Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Febuxostat Tablets Sales Quantity by Application (2018-2029)
6.2 Global Febuxostat Tablets Consumption Value by Application (2018-2029)
6.3 Global Febuxostat Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Febuxostat Tablets Sales Quantity by Type (2018-2029)
7.2 North America Febuxostat Tablets Sales Quantity by Application (2018-2029)
7.3 North America Febuxostat Tablets Market Size by Country
7.3.1 North America Febuxostat Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Febuxostat Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Febuxostat Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Febuxostat Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Febuxostat Tablets Market Size by Country
8.3.1 Europe Febuxostat Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Febuxostat Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Febuxostat Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Febuxostat Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Febuxostat Tablets Market Size by Region
9.3.1 Asia-Pacific Febuxostat Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Febuxostat Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Febuxostat Tablets Sales Quantity by Type (2018-2029)
10.2 South America Febuxostat Tablets Sales Quantity by Application (2018-2029)
10.3 South America Febuxostat Tablets Market Size by Country
10.3.1 South America Febuxostat Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Febuxostat Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Febuxostat Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Febuxostat Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Febuxostat Tablets Market Size by Country
11.3.1 Middle East & Africa Febuxostat Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Febuxostat Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Febuxostat Tablets Market Drivers
12.2 Febuxostat Tablets Market Restraints
12.3 Febuxostat Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Febuxostat Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Febuxostat Tablets
13.3 Febuxostat Tablets Production Process
13.4 Febuxostat Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Febuxostat Tablets Typical Distributors
14.3 Febuxostat Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
• 日本語訳：フェブキソスタット錠の世界市場2023：40mg、80mg
• レポートコード：MRC309Z7851 ▷ お問い合わせ（見積依頼・ご注文・質問）